文献速递老年精神精神分裂症与精神病性障碍

快放电小清蛋白阳性中间神经元:痴呆治疗的新视角与未来挑战

Fast-spiking parvalbumin-positive interneurons: new perspectives of treatment and future challenges in dementia.
PubMed 文献 · Mol Psychiatry · 2024-12-18

本文综述中枢神经系统小清蛋白阳性中间神经元(PV-INs)的生理特性及其丢失在痴呆认知 decline 中的作用,重点讨论阿尔茨海默病与血管性痴呆,并探讨其作为新型治疗靶点的潜力。

要点

  • PV-INs对多种应激高度脆弱,其丢失与痴呆记忆损害相关,但精确分子机制尚不明确。
  • PV-INs影响脑发育,其特性在不同类型痴呆中存在差异,丢失影响认知障碍的病因与进展。
  • 作者提出PV-INs可能作为痴呆治疗的新型靶点,并呼吁未来研究应对挑战。

核心结论

  • PV-INs丢失与痴呆记忆损害相关,但精确分子机制尚不明确,其作为新型治疗靶点的潜力有待探索。

研究设计与样本

  • 本文为综述,汇总PV-INs生理特性及其丢失在痴呆认知 decline 中作用的最新证据,重点聚焦阿尔茨海默病与血管性痴呆。

主要发现

  • PV-INs对多种应激高度脆弱,在多种神经精神疾病尤其是认知障碍相关疾病(如阿尔茨海默病、血管性痴呆、路易体痴呆和精神分裂症)的病理过程中起重要作用。
  • PV-INs丢失与痴呆记忆损害相关,但精确分子机制尚不明确。
  • PV-INs影响脑发育,其特性在不同类型痴呆中存在差异,丢失影响认知障碍的病因与进展。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Central nervous system parvalbumin-positive interneurons (PV-INs) are crucial and highly vulnerable to various stressors. They also play a significant role in the pathological processes of many neuropsychiatric diseases, especially those associated with cognitive impairment, such as Alzheimer's disease (AD), vascular dementia (VD), Lewy body dementia, and schizophrenia. Although accumulating evidence suggests that the loss of PV-INs is associated with memory impairment in dementia, the precise molecular mechanisms remain elusive. In this review, we delve into the current evidence regarding the physiological properties of PV-INs and summarize the latest insights into how their loss contributes to cognitive decline in dementia, particularly focusing on AD and VD. Additionally, we discuss the influence of PV-INs on brain development, the variations in their characteristics across different types of dementia, and how their loss affects the etiology and progression of cognitive impairments. Ultimately, our goal is to provide a comprehensive overview of PV-INs and to consider their potential as novel therapeutic targets in dementia treatment.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhang X, Wu M, Cheng L, et al. Fast-spiking parvalbumin-positive interneurons: new perspectives of treatment and future challenges in dementia. Mol Psychiatry. 2024. PMID: 39695324. doi:10.1038/s41380-024-02756-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。